Development Pipeline
![](https://www.efbiotech.com/wordpress/wp-content/uploads/2023/06/2.png)
![](https://www.efbiotech.com/wordpress/wp-content/uploads/2023/06/14-1.png)
Pipeline
Status
EF-001 (Cerebraca® Wafer)
EF-009 Wafer
HK-001
EF-031
TSCA-001
EF-011
EF-001 (Cerebraca® Wafer)
Brain Tumor Treatment | Implant
- IND application approved by USFDA and TFDA
- Orphan drug Designation (USFDA)
- A phase 1/2a clinical trial in Taiwan (CSR will be finalized by end of May in 2024)
- click for more information
EF-009 Wafer
Pancreatic Cancer Treatment | Implant
- IND application approved by USFDA and TFDA
- click for more information
HK-001
ALS Treatment | Oral Dosage Form
- IND application approved by USFDA and TFDA
- A phase 1 clinical trial in Taiwan is ongoing
- click for more information
EF-031
Solid Tumors Treatment | Oral Dosage Form
- Pre-clinical studies
- Prepared for IND application
- click for more information
TSCA-001
Spinocerebellar Ataxia Treatment | Oral Dosage Form
- Pre-clinical studies
- click for more information
EF-011
Idiopathic Pulmonary Fibrosis Treatment | Oral Dosage Form
- Pre-clinical studies
- click for more information
![](https://www.efbiotech.com/wordpress/wp-content/uploads/2024/05/Our-Pipeline-–-diversified-portfolio-to-increase-the-successful-rate-and-market-value-1-1024x576.png)
Partnering and Collaboration
![](https://www.efbiotech.com/wordpress/wp-content/uploads/2023/03/Partnering-And-Collaboration-1024x576.png)
![](https://www.efbiotech.com/wordpress/wp-content/uploads/2023/10/collaboration-1024x1024.png)
Strategic Partnerships
- - -
Open to Collaborative Drug Development and Manufacturing
![](https://www.efbiotech.com/wordpress/wp-content/uploads/2023/10/out-licensing-1024x1024.png)
Out-licensing
- - -
Seeking Technology Licensing and Pharmaceutical Partnerships
![](https://www.efbiotech.com/wordpress/wp-content/uploads/2023/10/in-licensing-1024x1024.png)
In-licensing
- - -
Actively Exploring Collaborations for Promising Drugs and Combination Therapies
EFB is looking for the opportunity to cooperate with international pharmaceutical companies or venture capitals.
Please mail us on efbiotech@efbiotech.com
Partner
![長弘合作夥伴:佛教慈濟醫療財團法人](https://www.efbiotech.com/wordpress/wp-content/uploads/2023/04/TCMF.png)
![長弘合作夥伴:國立東華大學](https://www.efbiotech.com/wordpress/wp-content/uploads/2023/04/NDHU.png)
![長弘合作夥伴:中國醫藥大學](https://www.efbiotech.com/wordpress/wp-content/uploads/2023/04/CMU.png)
![](https://www.efbiotech.com/wordpress/wp-content/uploads/2024/02/logo.nchu_-1024x272.jpg)
![長弘合作夥伴:花蓮慈濟醫院](https://www.efbiotech.com/wordpress/wp-content/uploads/2023/04/TCH.png)
![長弘合作夥伴:三軍總醫院](https://www.efbiotech.com/wordpress/wp-content/uploads/2023/04/TSGH.png)
![長弘合作夥伴:台中榮民總醫院](https://www.efbiotech.com/wordpress/wp-content/uploads/2023/04/TVGH.png)